Korean J Radiol.  2019 Apr;20(4):609-620. 10.3348/kjr.2018.0696.

Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology

• Hahn SY
• Shin JH
• Na DG
• Ha EJ
• Ahn HS
• Lim HK
• Lee JH
• Park JS
• Kim JH
• Sung JY
• Lee JH
• Baek JH
• Yoon JH
• Sim JS
• Lee KH
• Baek SM
• Jung SL
• Kim YK
• Choi YJ
• Korean Society of Radiology

• KMID: 2440484
• DOI: http://doi.org/10.3348/kjr.2018.0696

Abstract

Minimally invasive treatment of symptomatic thyroid nodules is now commonplace. Ethanol ablation (EA) of thyroid cystic nodules has been performed since the 1990s, but there is no global consensus or guideline. Although various limitations of EA have been described, recommendations for practical application are necessary. Therefore, the Task Force Committee of the Korean Society of Thyroid Radiology initiated the present consensus statement and here we provide recommendations for the role of EA in the management of symptomatic thyroid nodules. These recommendations are based on evidence to date from the literature and expert opinion.

Keyword

Thyroid; Thyroid neoplasm; Ethanol ablation; Minimally invasive therapy; Guidelines

MeSH Terms

Advisory Committees
Consensus*
Ethanol*
Expert Testimony
Thyroid Gland*
Thyroid Neoplasms
Thyroid Nodule*
Ethanol

Figure

• 

  Fig. 1 EA for benign recurrent cyst in right thyroid gland.A. 18-gauge needle inserted into center of cystic area via trans-isthmic approach route. B. After aspiration of internal fluid, ethanol was slowly injected into cystic space. EA = ethanol ablation

• 

  Fig. 2 EA for recurrent papillary thyroid carcinoma in right lateral neck.A. 23-gauge needle inserted into most peripheral portion of recurrent cancer. B. Immediately after injection of ethanol, treated area became echogenic.

Reference

1. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007; 36:707–735. viPMID: 17673125.

2. Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA. 2015; 313:926–935. PMID: 25734734.

3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1–133. PMID: 26462967.

4. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules--2016 update. Endocr Pract. 2016; 22:622–639. PMID: 27167915.

5. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab. 1998; 83:3881–3885. PMID: 9814462.

6. Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab. 2002; 87:4928–4934. PMID: 12414852.

7. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002; 87:4154–4159. PMID: 12213864.

8. Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008; 393:667–673. PMID: 18633639.

9. Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP. Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec. 2013; 75:6–17. PMID: 23486083.

10. Hegedüs L. Therapy: a new nonsurgical therapy option for benign thyroid nodules? Nat Rev Endocrinol. 2009; 5:476–478. PMID: 19690558.

11. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol. 2016; 17:370–395. PMID: 27134526.

12. Crile G Jr. Treatment of thyroid cysts by aspiration. Surgery. 1966; 59:210–212. PMID: 5913492.

13. Miller JM, Zafar SU, Karo JJ. The cystic thyroid nodule. Recognition and management. Radiology. 1974; 110:257–261. PMID: 4810134.

14. Sykes D. The solitary thyroid nodule. Br J Surg. 1981; 68:510–512. PMID: 7248725.

15. Hegedüs L, Hansen JM, Karstrup S, Torp-Pedersen S, Juul N. Tetracycline for sclerosis of thyroid cysts. A randomized study. Arch Intern Med. 1988; 148:1116–1118. PMID: 3284501.

16. Ryan WG, Dwarakanathan A. Minor complication of thyroid cyst sclerosis with tetracycline. Arch Intern Med. 1986; 146:201–202.

17. Rozman B, Bencezigman Z, Tomicbrzac H, Skreb F, Pavlinovic Z, Simonovic I. Sclerosation of thyroid cysts by ethanol. Periodicum Biologorum. 1990; 91:453.

18. Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino A. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology. 1994; 190:529–533. PMID: 8284411.

19. Yasuda K, Ozaki O, Sugino K, Yamashita T, Toshima K, Ito K, et al. Treatment of cystic lesions of the thyroid by ethanol instillation. World J Surg. 1992; 16:958–961. PMID: 1462637.

20. Martino E, Murtas ML, Loviselli A, Piga M, Petrini L, Miccoli P, et al. Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery. 1992; 112:1161–1164. discussion 1164-1165. PMID: 1455319.

21. Papini E, Panunzi C, Pacella CM, Bizzarri G, Fabbrini R, Petrucci L, et al. Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J Clin Endocrinol Metab. 1993; 76:411–416. PMID: 8432784.

22. Goletti O, Monzani F, Lenziardi M, Lippolis PV, De Negri F, Caraccio N, et al. Cold thyroid nodules: a new application of percutaneous ethanol injection treatment. J Clin Ultrasound. 1994; 22:175–178. PMID: 8169237.

23. Bennedbaek FN, Hegedüs L. Alcohol sclerotherapy for benign solitary solid cold thyroid nodules. Lancet. 1995; 346:1227.

24. Bennedbaek FN, Karstrup S, Hegedüs L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol. 1997; 136:240–250. PMID: 9100545.

25. Lippi F, Ferrari C, Manetti L, Rago T, Santini F, Monzani F, et al. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The multicenter study group. J Clin Endocrinol Metab. 1996; 81:3261–3264. PMID: 8784080.

26. Papini E, Pacella CM, Verde G. Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid. 1995; 5:147–150. PMID: 7647576.

27. Zingrillo M, Collura D, Ghiggi MR, Nirchio V, Trischitta V. Treatment of large cold benign thyroid nodules not eligible for surgery with percutaneous ethanol injection. J Clin Endocrinol Metab. 1998; 83:3905–3907. PMID: 9814466.

28. Bennedbaek FN, Hegedüs L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab. 2003; 88:5773–5777. PMID: 14671167.

29. Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol. 2008; 18:835–842. PMID: 18040692.

30. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol. 2002; 178:699–704. PMID: 11856701.

31. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006; 244:296–304. PMID: 16858194.

32. Lim CY, Yun JS, Lee J, Nam KH, Chung WY, Park CS. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid. 2007; 17:347–350. PMID: 17465865.

33. Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, et al. Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab. 2011; 96:2750–2755. PMID: 21715533.

34. Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery. 2013; 154:1448–1454. discussion 1454-1455. PMID: 24176579.

35. Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol. 2013; 24:672–679. PMID: 23622038.

36. Lee N, Tuttle M. The role of external beam radiotherapy in the treatment of papillary thyroid cancer. Endocr Relat Cancer. 2006; 13:971–977. PMID: 17158749.

37. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004; 114:393–402. PMID: 15091208.

38. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001; 130:971–977. PMID: 11742325.

39. Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol. 2011; 197:W331–W336. PMID: 21785061.

40. Long B, Li L, Yao L, Chen S, Yi H, Ye X, et al. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma. J Cancer Res Ther. 2015; 11(Suppl):C244–C247. PMID: 26612446.

41. Park KW, Shin JH, Han BK, Ko EY, Chung JH. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol. 2011; 18:2564–2568. PMID: 21347777.

42. Zhao Q, Tian G, Kong D, Jiang T. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers. J Endocrinol Invest. 2016; 39:909–916. PMID: 26980591.

43. Wang L, Ge M, Xu D, Chen L, Qian C, Shi K, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Cancer Res Ther. 2014; 10(Suppl):C144–C149. PMID: 25450273.

44. Lee SJ, Jung SL, Kim BS, Ahn KJ, Choi HS, Lim DJ, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol. 2014; 15:817–826. PMID: 25469095.

45. Lim HK, Baek JH, Lee JH, Kim WB, Kim TY, Shong YK, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015; 25:163–170. PMID: 25199815.

46. Kim JH, Yoo WS, Park YJ, Park DJ, Yun TJ, Choi SH, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015; 276:909–918. PMID: 25848897.

47. Sung JY, Baek JH, Kim KS, Lee D, Yoo H, Kim JK, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013; 269:293–300. PMID: 23616630.

48. Baek JH, Ha EJ, Choi YJ, Sung JY, Kim JK, Shong YK. Radiofrequency versus Ethanol Ablation for Treating Predominantly cystic thyroid nodules: a randomized clinical trial. Korean J Radiol. 2015; 16:1332–1340. PMID: 26576124.

49. Suh CH, Baek JH, Ha EJ, Choi YJ, Lee JH, Kim JK, et al. Ethanol ablation of predominantly cystic thyroid nodules: evaluation of recurrence rate and factors related to recurrence. Clin Radiol. 2015; 70:42–47. PMID: 25443776.

50. Monzani F, Caraccio N, Goletti O, Lippolis PV, Casolaro A, Del Guerra P, et al. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf). 1997; 46:9–15. PMID: 9059552.

51. Verde G, Papini E, Pacella CM, Gallotti C, Delpiano S, Strada S, et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf). 1994; 41:719–724. PMID: 7889606.

52. Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG. Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol. 2003; 180:1723–1726. PMID: 12760950.

53. Kim DW, Rho MH, Kim HJ, Kwon JS, Sung YS, Lee SW. Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous? AJNR Am J Neuroradiol. 2005; 26:2122–2127. PMID: 16155169.

54. Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract. 2004; 10:269–275. PMID: 15310546.

55. Jang SW, Baek JH, Kim JK, Sung JY, Choi H, Lim HK, et al. How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol. 2012; 81:905–910. PMID: 21388767.

56. Monzani F, Lippi F, Goletti O, Del Guerra P, Caraccio N, Lippolis PV, et al. Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab. 1994; 78:800–802. PMID: 8126160.

57. Guglielmi R, Pacella CM, Bianchini A, Bizzarri G, Rinaldi R, Graziano FM, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid. 2004; 14:125–131. PMID: 15068627.

58. Monzani F, Goletti O, Caraccio N, Del Guerra P, Ferdeghini M, Pucci E, et al. Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation. Clin Endocrinol (Oxf). 1992; 36:491–497. PMID: 1617800.

59. Mazzeo S, Toni MG, De Gaudio C, Caramella D, Pinto F, Lencioni R, et al. Percutaneous injection of ethanol to treat autonomous thyroid nodules. AJR Am J Roentgenol. 1993; 161:871–876. PMID: 8372778.

60. Di Lelio A, Rivolta M, Casati M, Capra M. Treatment of autonomous thyroid nodules: value of percutaneous ethanol injection. AJR Am J Roentgenol. 1995; 164:207–213. PMID: 7998541.

61. Tarantino L, Francica G, Sordelli I, Sperlongano P, Parmeggiani D, Ripa C, et al. Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. AJR Am J Roentgenol. 2008; 190:800–808. PMID: 18287455.

62. Kim DW, Rho MH, Park HJ, Kwag HJ. Ultrasonography-guided ethanol ablation of predominantly solid thyroid nodules: a preliminary study for factors that predict the outcome. Br J Radiol. 2012; 85:930–936. PMID: 22167503.

63. Livraghi T, Paracchi A, Ferrari C, Bergonzi M, Garavaglia G, Raineri P, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress. Radiology. 1990; 175:827–829. PMID: 2188302.

64. Tarantino L, Giorgio A, Mariniello N, de Stefano G, Perrotta A, Aloisio V, et al. Percutaneous ethanol injection of large autonomous hyperfunctioning thyroid nodules. Radiology. 2000; 214:143–148. PMID: 10644114.

65. Del Prete S, Russo D, Caraglia M, Giuberti G, Marra M, Vitale G, et al. Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40 ml: three years of follow-up. Clin Radiol. 2001; 56:895–901. PMID: 11603892.

66. Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013; 98:3949–3957. PMID: 23956350.

67. Shin JE, Baek JH, Lee JH. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol. 2013; 25:14–19. PMID: 23079931.

68. Sung JY, Baek JH, Jung SL, Kim JH, Kim KS, Lee D, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid. 2015; 25:112–117. PMID: 25320840.

69. Paschke R, Hegedüs L, Alexander E, Valcavi R, Papini E, Gharib H. Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol. 2011; 7:354–361. PMID: 21364517.

70. Papini E, Pacella CM, Hegedus L. Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur J Endocrinol. 2014; 170:R133–R146. PMID: 24459238.

71. Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015; 36:1321–1325. PMID: 25814656.

72. Seo SH, Kim TH, Kim SH, Lee SH, Kim JT, Park DW, et al. Predicting the size of benign thyroid nodules and analysis of associated factors that affect nodule size. Chonnam Med J. 2015; 51:97–101. PMID: 26306305.

73. Bernardi S, Stacul F, Michelli A, Giudici F, Zuolo G, de Manzini N, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017; 57:402–408. PMID: 27848197.

74. Sohn YM, Hong SW, Kim EK, Kim MJ, Moon HJ, Kim SJ, et al. Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation. Thyroid. 2009; 19:317–319. PMID: 19207007.

75. Vannucchi G, Covelli D, Perrino M, De Leo S, Fugazzola L. Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes. Endocrine. 2014; 47:648–651. PMID: 24610207.

76. Suh CH, Baek JH, Choi YJ, Lee JH. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016; 26:420–428. PMID: 26782174.

77. Kim SY, Kim SM, Chang H, Kim BW, Lim CY, Lee YS, et al. Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer. Eur Arch Otorhinolaryngol. 2017; 274:3497–3501. PMID: 28664330.

78. Hay ID, Charboneau JW. The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2011; 96:2717–2720. PMID: 21896899.

79. Goyal RM, Jonklaas J, Burman KD. Management of recurrent cervical papillary thyroid cancer. Endocrinol Metab Clin North Am. 2014; 43:565–572. PMID: 24891178.

80. Fontenot TE, Deniwar A, Bhatia P, Al-Qurayshi Z, Randolph GW, Kandil E. Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer: a systematic review and pooled analysis. JAMA Otolaryngol Head Neck Surg. 2015; 141:512–518. PMID: 25928119.

81. Jeong SY, Baek JH, Choi YJ, Lee JH. Ethanol and thermal ablation for malignant thyroid tumours. Int J Hyperthermia. 2017; 33:938–945. PMID: 28797186.

82. Goletti O, Lenziardi M, De Negri F, Fiorini I, Lippolis PV, Cristofani E, et al. Inoperable thyroid carcinoma: palliation with percutaneous injection of ethanol. Eur J Surg. 1993; 159:639–641. PMID: 7510524.

83. Isozaki T, Kiba T, Numata K, Saito S, Shimamura T, Kitamura T, et al. Medullary thyroid carcinoma with multiple hepatic metastases: treatment with transcatheter arterial embolization and percutaneous ethanol injection. Intern Med. 1999; 38:17–21. PMID: 10052736.

84. Akasu H, Shimizu K, Kitagawa W, Naito Z, Kawanami O, Tanaka S. Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy. Pathol Int. 2002; 52:406–409. PMID: 12100524.

85. Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010; 27:391–399. PMID: 22550381.

86. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011; 258:351–369. PMID: 21273519.

87. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010; 194:1137–1142. PMID: 20308523.

88. Ahn HS, Kim SJ, Park SH, Seo M. Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography. Ultrasonography. 2016; 35:244–252. PMID: 27101983.

89. Ko ES, Sung JY, Shin JH. Intralesional saline injection for effective ultrasound-guided aspiration of benign viscous cystic thyroid nodules. Ultrasonography. 2014; 33:122–127. PMID: 24936505.

90. Sung JY, Baek JH, Kim YS, Jeong HJ, Kwak MS, Lee D, et al. One-step ethanol ablation of viscous cystic thyroid nodules. AJR Am J Roentgenol. 2008; 191:1730–1733. PMID: 19020243.

91. Kim SM, Baek JH, Kim YS, Sung JY, Lim HK, Choi H, et al. Efficacy and safety of ethanol ablation for thyroglossal duct cysts. AJNR Am J Neuroradiol. 2011; 32:306–309. PMID: 21087937.

92. Cho YS, Lee HK, Ahn IM, Lim SM, Kim DH, Choi CG, et al. Sonographically guided ethanol sclerotherapy for benign thyroid cysts: results in 22 patients. AJR Am J Roentgenol. 2000; 174:213–216. PMID: 10628481.

93. Zingrillo M, Torlontano M, Ghiggi MR, D'Aloiso L, Nirchio V, Bisceglia M, et al. Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid. 1996; 6:403–408. PMID: 8936663.

94. Zingrillo M, Torlontano M, Chiarella R, Ghiggi MR, Nirchio V, Bisceglia M, et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid. 1999; 9:763–767. PMID: 10482367.

95. Kim YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Sung JY, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012; 22:1573–1578. PMID: 22437920.

96. Sung JY, Kim YS, Choi H, Lee JH, Baek JH. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol. 2011; 196:W210–W214. PMID: 21257865.

97. Del Prete S, Caraglia M, Russo D, Vitale G, Giuberti G, Marra M, et al. Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid. 2002; 12:815–821. PMID: 12481948.

98. Park NH, Kim DW, Park HJ, Lee EJ, Park JS, Park SI, et al. Thyroid cysts treated with ethanol ablation can mimic malignancy during sonographic follow-up. J Clin Ultrasound. 2011; 39:441–446. PMID: 21898879.

99. Zingrillo M, Ghiggi MR, Liuzzi A. A large, nonfunctioning parathyroid cyst recurring after aspiration and subsequently cured by percutaneous ethanol injection. J Clin Ultrasound. 1996; 24:378–382. PMID: 8873863.

100. Lee SJ, Ahn IM. Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: long-term follow-up experience. Endocr J. 2005; 52:455–462. PMID: 16127215.

101. Bennedbaek FN, Nielsen LK, Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 1998; 83:830–835. PMID: 9506736.

102. Caraccio N, Goletti O, Lippolis PV, Casolaro A, Cavina E, Miccoli P, et al. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience. Thyroid. 1997; 7:699–704. PMID: 9349572.

103. Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg. 2010; 34:1488–1493. PMID: 20376445.

104. Rodríguez-Lomba E, Molina-López I, Parra-Blanco V, Suárez-Fernández R, Ciudad-Blanco C. Cutaneous implantation of papillary thyroid carcinoma secondary to percutaneous ethanol injection into nodal metastasis. J Eur Acad Dermatol Venereol. 2018; 32:e11–e13. PMID: 28653452.